Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
23(10):3091-3101
indicating that NHC-TP competes predominantly with CTP for incorporation
[O-]S(=O)(=O)CCCCOC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@H]5[C@H](CO)O[C@@H](O[C@H]6[C@H](CO)O[C@@H](O[C@H]7[C@H](CO)O[C@@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2OCCCCS([O-])(=O)=O)[C@H](O)[C@H]8O)[C@@H](O)[C@@H]7O)[C@@H](O)[C@@H]6O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O
InChi: InChI=1S/C18H20N2O12/c21-11-1-2-12(22)19(11)31-17(27)7-5-15(25)29-9-10-30-16(26)6-8-18(28)32-20-13(23)3-4-14(20)24/h1-10H2
Mito-LND Catalog No.:M24336-C 23(10):3091-3101Mito LND (Mito Lonidamine) is an orally active and mitochondria targeted inhibitor of oxidative phosphorylation (OXPHOS). Mito LND inhibits mitochondrial bioenergetics, stimulates the formation of reactive oxygen species, and induces autophagic cell death in lung cancer cells. Product information CAS Number: 2361564 49 8 Molecular Weight: 801. 62 Formula: C43H45BrCl2N3OP Chemical Name: [10 ({1 [(2,4 dichlorophenyl)methyl] 1H indazol 3
US$ 38.00
US$ 235.70
US$ 38.00
US$ 38.00
US$ 90.00